Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in hiv-infected women. mtct-plus program, abidjan, côte d’ivoire

HIGHLIGHTS

• who: Côte d'Ivoire et al. from the The MTCT-Plus program was reviewed by the institutional review board (IRB) from Columbia University in , (principal sponsor) and was not considered a research project but rather a demonstration program in the context of the ARV roll-outAs an operational HIV care and treatment program MTCT-Plus program was exempted from review by the IRB from the Ministry of health of Côte d'Ivoire. have published the research: Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.